SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GLGC Gene Logic

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Lokness who wrote (197)4/23/2005 2:42:57 PM
From: Mike McFarland  Read Replies (1) of 360
 
From an interview with Tartaglia

"finding new indications for failed compounds"
"rescuing failed compounds"
"expand the market of live drugs"
"look at very advanced clinical compounds"
"the application of toxicogenomics"

Partly because the formatting was wrecked
I have not pasted the document--so go here:

It is the second hit, while it lasts...
google.com

Skip way down past the article about glgc for the
interview with Tartaglia. He mentions some interesting
stuff like mouse imagining experiments and genetic ADME.

If you get excited, read the third hit off of google
this morning--a newspaper article with
scathing comments from a Brendan Bogart...an investor
with Mel Capital in Emerson, N.J.
gazette.net
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext